Use of phenylephrine hydrochloride (or a pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in the production of a combination medicament for treating upper respiratory mucosal congestion, comprising combining such substances with excipients, characterised in that the medicament has the phenylephrine hydrochloride (or the pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in proportions suitable for, and the medicament is for, providing an adult with: a) 4 mg - 7.5 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine), in combination with 950 mg - 1,000 mg paracetamol； or b) 5 mg - 7.5 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine), in combination with 600 mg - 700 mg paracetamol； or c) 6 mg - 8 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine), in combination with 500 mg - 550 mg paracetamol.鹽酸苯福林(或苯福林的藥學上可接受的替代形式)和對乙酰氨基酚在生產用於治療上呼吸道粘膜充血的組合藥物中的用途，該藥物包括上述物質與賦形劑的組合，其特徵在於，所述藥物含有合適比例的鹽酸苯福林(或苯福林的藥學上可接受的替代形式)和對乙酰氨基酚，並且該藥物用於向成人提供：a)4mg-7.5mg鹽酸苯福林(或等效量的苯福林的藥學上可接受的替代形式)以及950mg-1000mg對乙酰氨基酚的組合；或b)5mg-7.5mg鹽酸苯福林(或等效量的苯福林的藥學上可接受的替代形式)以及600mg-700mg對乙酰氨基酚的組合；或c)6mg-8mg鹽酸苯福林(或等效量的苯福林的藥學上可接受的替代形式)以及500mg-550mg對乙酰氨基酚的組合。
